Dr. Behzad Aghazadeh, PhD is the Managing Partner and Portfolio Manager of Avoro Capital. He has over 25 years of experience in the biopharmaceutical industry spanning scientific research, management consulting, institutional investing, and board leadership.
Behzad received his master’s degree in Physics from the Ludwig-Maximilians-University and a PhD from Cornell University in Biochemistry & Biophysics. He began his career as a research scientist, before joining Booz Allen Hamilton. He has held investment roles at Bernstein Value Equities and Sio Capital Management. Behzad served as the Executive Chairman of Immunomedics, a company developing targeted oncology therapies, from 2017 until the company’s $21B acquisition by Gilead in 2020. He continues to serve on the boards of public and private biotechnology companies.
+1 212.937.4970